[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-370346-105":3,"detail-sidebar-cat-0-en-105":81,"doc-detail-370346-en":131},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":74,"head_meta":76,"extra_data":78,"updated_unix":80},105,"en","diagnostic-performance-of-radiolabelled-fapi-versus-18ffdg-pet-imaging-in-hepato-pancreato-biliary-oncology-a-systematic-review-and-meta-analysis","Diagnostic Performance of Radiolabelled FAPI Versus [18F]FDG PET Imaging in Hepato-Pancreato-Biliary Oncology - A Systematic Review and Meta-Analysis","","Radiolabelled fibroblast activation protein inhibitor (FAPI) tracers offer a potential alternative to 2-deoxy-2-[18F]fluoro-D-glucose ([18F]FDG) for improving diagnosis and staging of hepato-pancreato-biliary (HPB) cancers. This systematic review and meta-analysis compared radiolabelled FAPI with [18F]FDG PET imaging using detection rate and semi-quantitative tracer uptake. Twenty-eight eligible studies were included. Histopathology served as the reference standard for primary tumours in most studies (93%). Radiolabelled FAPI showed significantly higher detection in hepatocellular carcinoma and biliary tract cancer, while pancreatic cancer showed no differences. Lesion-based detection of nodal, hepatic and extra-hepatic metastases favored FAPI, and mean SUVmax was higher across all HPB cancer types.",{"@graph":14,"@context":73},[15,34,56],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/research-report/","Research & Report",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/diagnostic-performance-of-radiolabelled-fapi-versus-18ffdg-pet-imaging-in-hepato-pancreato-biliary-oncology-a-systematic-review-and-meta-analysis/370346/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/diagnostic-performance-of-radiolabelled-fapi-versus-18ffdg-pet-imaging-in-hepato-pancreato-biliary-oncology-a-systematic-review-and-meta-analysis/370346.png","ImageObject",300,407,{"name":42,"@type":43},"Miles","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-11-19","2026-09-23",true,{"@type":52,"interactionType":53,"userInteractionCount":55},"InteractionCounter",{"@type":54},"ViewAction",18,{"@type":57,"mainEntity":58},"FAQPage",[59,65,69],{"name":60,"@type":61,"acceptedAnswer":62},"What was the purpose of this systematic review and meta-analysis?","Question",{"text":63,"@type":64},"To compare the diagnostic performance of radiolabelled FAPI versus [18F]FDG PET imaging for hepato-pancreato-biliary (HPB) cancers, including primary tumours and liver metastases of gastrointestinal origin.","Answer",{"name":66,"@type":61,"acceptedAnswer":67},"How was diagnostic performance measured in the included studies?",{"text":68,"@type":64},"Performance was defined as a combination of detection rate and semi-quantitative tracer uptake.",{"name":70,"@type":61,"acceptedAnswer":71},"What were the main findings comparing FAPI and FDG PET?",{"text":72,"@type":64},"Radiolabelled FAPI outperformed [18F]FDG in detection rate for hepatocellular carcinoma and biliary tract cancer, showed no differences in pancreatic cancer, and had higher lesion-based detection of nodal, liver, and extra-hepatic metastases, with higher mean SUVmax across all HPB cancer types.","https://schema.org",{"og:url":32,"og:type":75,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":77,"canonical":32},"index,follow",{"doc_id":79,"site_id":7},370346,1790463537,{"code":4,"msg":82,"data":83},"success",[84,88,92,96,101,106,111,115,120,123,127],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":85,"show_sort_weight":86,"slug":87},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":89,"show_sort_weight":90,"slug":91},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":93,"show_sort_weight":94,"slug":95},"Exam",70,"exam",{"id":97,"doc_module":4,"doc_module_name":25,"category_name":98,"show_sort_weight":99,"slug":100},5,"Comic",60,"comic",{"id":102,"doc_module":4,"doc_module_name":25,"category_name":103,"show_sort_weight":104,"slug":105},6,"Technology",50,"technology",{"id":107,"doc_module":4,"doc_module_name":25,"category_name":108,"show_sort_weight":109,"slug":110},7,"Healthcare",40,"healthcare",{"id":112,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":113,"slug":114},8,30,"research-report",{"id":116,"doc_module":4,"doc_module_name":25,"category_name":117,"show_sort_weight":118,"slug":119},9,"Religion & Spirituality",20,"religion-spirituality",{"id":118,"doc_module":4,"doc_module_name":25,"category_name":121,"show_sort_weight":118,"slug":122},"World Cup","world-cup",{"id":124,"doc_module":4,"doc_module_name":25,"category_name":125,"show_sort_weight":124,"slug":126},10,"Lifestyle","lifestyle",{"id":128,"doc_module":4,"doc_module_name":25,"category_name":129,"show_sort_weight":97,"slug":130},19,"General","general",{"code":4,"msg":82,"data":132},{"doc_id":79,"user_id":133,"nickname":42,"user_avatar":134,"doc_module":4,"category_id":112,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":135,"file_id":136,"file_url":137,"file_type":138,"file_size":139,"view_count":55,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":140,"language":141,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":142,"faqs":143,"seo_title":144,"seo_description":12,"update_tm":145,"read_time":109,"preview_page_count":33,"preview_urls":146},13056703019404,"https://ap-avatar.wpscdn.com/davatar_29158cc5080c5b710cf443261637dec0","Review  \nDiagnostic Performance of Radiolabelled FAPI Versus [18 F]FDG PET Imaging in Hepato-Pancreato-Biliary Oncology: A Systematic Review and Meta-Analysis  \nRutger B. Henrar 1,2, Floris A. Vuijk 3, George L. Burchell 4, Susan van Dieren 1,2, Lioe-Fee de Geus-Oei 5, Geert Kazemier 1,2, Alexander L. Vahrmeijer 3, Daniela E. Oprea-Lager 2,6,† and Rutger-Jan Swijnenburg 1,2, *,†  \nAcademic Editor: Antonio Di Stefano  \nReceived: 16 December 2024  \nRevised: 17 February 2025  \nAccepted: 18 February 2025  \nPublished: 25 February 2025  \nCitation: Henrar, R.B.; Vuijk, F.A.; Burchell, G.L.; van Dieren, S.; de Geus-Oei, L.-F.; Kazemier, G.;  \nVahrmeijer, A.L.; Oprea-Lager, D.E.; Swijnenburg, R.-J. Diagnostic Performance of Radiolabelled FAPI Versus [18F]FDGPET Imaging in Hepato-Pancreato-Biliary Oncology:  \nA Systematic Review and MetaAnalysis. Int. J. Mol. Sci. 2025, 26, 1978 . [https://doi.org/10.3390/ijms26051978](https://doi.org/10.3390/ijms26051978)  \n[Copyright:](Copyright:) © 2025 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license ([https://creativecommons.org/](https://creativecommons.org/)[ ](https://creativecommons.org/)[licenses/by/4.0/](licenses/by/4.0/)) .  \n1 Department of Surgery, Amsterdam UMC Location Vrije Universiteit Amsterdam, de Boelelaan 1117, 1081 HV Amsterdam, The Netherlands; [r.b.henrar@amsterdamumc.nl](r.b.henrar@amsterdamumc.nl) (R.B.H.); [s.vandieren@amsterdamumc.nl](s.vandieren@amsterdamumc.nl) (S.v.D.); [g.kazemier@amsterdamumc.nl](g.kazemier@amsterdamumc.nl) (G.K.)  \n2 Cancer Center Amsterdam, Imaging and Biomarkers, Van der Boechorststraat 6B, 1081 BT Amsterdam, The Netherlands; [daniela.oprea-lager@radboudumc.nl](daniela.oprea-lager@radboudumc.nl)  \n3 Department of Surgery, Leiden University Medical Center, Albinusdreef 2, 2333 ZA Leiden, The Netherlands; [f.a.vuijk@lumc.nl](f.a.vuijk@lumc.nl) (F.A.V.); [a.l.vahrmeijer@lumc.nl](a.l.vahrmeijer@lumc.nl) (A.L.V.)  \n4 Medical Library, Vrije Universiteit Amsterdam, de Boelelaan 1118, 1081 HV Amsterdam, The Netherlands; [g.b.burchell@vu.nl](g.b.burchell@vu.nl)  \n5 Department of Radiology, Leiden University Medical Center, Albinusdreef 2, 2333 ZA Leiden, The Netherlands; [l.f.de_geus-oei@lumc.nl](l.f.de_geus-oei@lumc.nl)  \n6 Department of Medical Imaging, Radboud University Medical Center, Geert Grootplein Zuid 10, 6525 GA Nijmegen, The Netherlands  \n* Correspondence: [r.j.swijnenburg@amsterdamumc.nl](r.j.swijnenburg@amsterdamumc.nl)[ ](r.j.swijnenburg@amsterdamumc.nl)† These authors contributed equally to this work.  \nAbstract: Radiolabelled fibroblast activation protein inhibitor (FAPI) tracers have the potential to overcome the limitations of 2-deoxy-2-[18F]fluoro-D-glucose ([18F]FDG) and improve the diagnosis and staging of hepato-pancreato-biliary (HPB) cancers. This study aims to compare the diagnostic performance of radiolabelled FAPI versus [18F]FDG PET imaging in HPB cancers. A systematic search of PubMed, Embase, Web of Science and Cochrane Library was performed to identify eligible studies on the diagnostic performance of FAPI PET for primary HPB tumours (hepatocellular carcinoma (HCC), pancreatic cancer (PC) and biliary tract cancer (BTC)) and for liver metastases of gastrointestinal origin. The diagnostic performance was defined as a combination of detection rate and semi-quantitative tracer uptake. A random-effects model was used to calculate the risk differences. In total, 28 studies were included. Histopathology was the reference standard for the primary tumour in 26 studies (93%). The detection rate of radiolabelled FAPI in comparison to [18F]FDG was significantly higher in HCC (0.33, 95% CI: 0.20–0.47 and 0.34, 95% CI: 0.23–0.45) and BTC (0.27, 95% CI: 0.11–0.43 and 0.28, 95% CI: 0.08–0.48), in the patient-and lesion-based analyses, respectively. In PC, no differences were observed. Radiolabelled FAPI outper","cbCaieq7nXRFJlZa","https://ap.wps.com/l/cbCaieq7nXRFJlZa","pdf",2916554,16,"English","# Introduction\n## Rationale and current diagnostic work-up\n## Limitations of anatomical imaging\n## Molecular imaging and study objective\n# Methods\n## Search strategy and included studies\n## Definition of diagnostic performance\n## Statistical approach\n# Results\n## Included study characteristics and reference standards\n## Detection rate comparisons (HCC, PC, BTC)\n## Lesion-based metastatic detection\n## Tracer uptake (SUVmax)\n# Discussion\n## Overall benefits of FAPI PET in HPB oncology","[{\"question\":\"What was the purpose of this systematic review and meta-analysis?\",\"answer\":\"To compare the diagnostic performance of radiolabelled FAPI versus [18F]FDG PET imaging for hepato-pancreato-biliary (HPB) cancers, including primary tumours and liver metastases of gastrointestinal origin.\"},{\"question\":\"How was diagnostic performance measured in the included studies?\",\"answer\":\"Performance was defined as a combination of detection rate and semi-quantitative tracer uptake.\"},{\"question\":\"What were the main findings comparing FAPI and FDG PET?\",\"answer\":\"Radiolabelled FAPI outperformed [18F]FDG in detection rate for hepatocellular carcinoma and biliary tract cancer, showed no differences in pancreatic cancer, and had higher lesion-based detection of nodal, liver, and extra-hepatic metastases, with higher mean SUVmax across all HPB cancer types.\"}]","Diagnostic Performance of Radiolabelled FAPI Versus [18F]FDG PET Imaging in Hepato-Pancreato-Biliary Oncology - A Systematic Review and Meta-Analysis | PDF",1790188140,[147,151,155,159],{"page_no":22,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/a67800052987250b4baaacec8516c452.webp",983,1390,{"page_no":26,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/6659803baf0a51b9c870606a855a5b12.webp",982,1388,{"page_no":30,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/aa6fb889dbf465916c27313f31892378.webp",981,1387,{"page_no":33,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/16fd583b5daa8ee46f91a7755004237a.webp",980,1385]